Port Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $249K | Buy |
+8,859
| New | +$236K | 0.01% | 79 |
|
|
2025
Q4 | – | Sell |
-9,219
| Closed | -$235K | – | 84 |
|
|
2025
Q3 | $235K | Buy |
9,219
+342
| +4% | +$8.44K | 0.01% | 82 |
|
|
2025
Q2 | $215K | Sell |
8,877
-800
| -8% | -$18.7K | 0.01% | 83 |
|
|
2025
Q1 | $245K | Sell |
9,677
-162
| -2% | -$4.24K | 0.01% | 79 |
|
|
2024
Q4 | $261K | Buy |
9,839
+1,881
| +24% | +$51K | 0.01% | 82 |
|
|
2024
Q3 | $230K | Sell |
7,958
-1,428
| -15% | -$41.7K | 0.01% | 84 |
|
|
2024
Q2 | $263K | Sell |
9,386
-109
| -1% | -$3K | 0.01% | 78 |
|
|
2024
Q1 | $263K | Buy |
9,495
+153
| +2% | +$4.25K | 0.01% | 80 |
|
|
2023
Q4 | $269K | Buy |
9,342
+310
| +3% | +$9.37K | 0.02% | 80 |
|
|
2023
Q3 | $300K | Buy |
9,032
+73
| +0.8% | +$2.58K | 0.02% | 72 |
|
|
2023
Q2 | $329K | Buy |
8,959
+229
| +3% | +$8.91K | 0.02% | 71 |
|
|
2023
Q1 | $356K | Sell |
8,730
-1,405
| -14% | -$60.7K | 0.02% | 64 |
|
|
2022
Q4 | $519K | Sell |
10,135
-524
| -5% | -$25.1K | 0.04% | 54 |
|
|
2022
Q3 | $466K | Buy |
10,659
+668
| +7% | +$32.5K | 0.04% | 53 |
|
|
2022
Q2 | $524K | Sell |
9,991
-302
| -3% | -$15.4K | 0.04% | 55 |
|
|
2022
Q1 | $533K | Buy |
10,293
+164
| +2% | +$8.51K | 0.04% | 56 |
|
|
2021
Q4 | $598K | Sell |
10,129
-193
| -2% | -$9.56K | 0.04% | 59 |
|
|
2021
Q3 | $444K | Sell |
10,322
-147
| -1% | -$6.51K | 0.02% | 63 |
|
|
2021
Q2 | $410K | Buy |
10,469
+81
| +0.8% | +$3.15K | 0.02% | 64 |
|
|
2021
Q1 | $376K | Sell |
10,388
-2,585
| -20% | -$91.8K | 0.02% | 72 |
|
|
2020
Q4 | $478K | Sell |
12,973
-518
| -4% | -$19K | 0.03% | 68 |
|
|
2020
Q3 | $470K | Sell |
13,491
-107
| -0.8% | -$3.75K | 0.04% | 62 |
|
|
2020
Q2 | $422K | Buy |
13,598
+224
| +2% | +$7.61K | 0.04% | 61 |
|
|
2020
Q1 | $414K | Sell |
13,374
-42
| -0.3% | -$1.43K | 0.06% | 62 |
|
|
2019
Q4 | $499K | Hold |
13,416
| – | – | 0.06% | 71 |
|
|
2019
Q3 | $457K | Sell |
13,416
-282
| -2% | -$10.3K | 0.05% | 84 |
|
|
2019
Q2 | $563K | Sell |
13,698
-2,550
| -16% | -$101K | 0.07% | 77 |
|
|
2019
Q1 | $655K | Buy |
16,248
+35
| +0.2% | +$1.4K | 0.09% | 75 |
|
|
2018
Q4 | $671K | Sell |
16,213
-65
| -0.4% | -$2.7K | 0.1% | 79 |
|
|
2018
Q3 | $681K | Buy |
+16,278
| New | +$627K | 0.08% | 98 |
|
Other funds holding PFE
VCM
VPM
Port Capital's PFE Position: Q1 2026 in Review
Port Capital opened a new position in Pfizer (PFE) in Q1 2026: 8,859 shares worth $249K. The stake represents 0.01% of the portfolio and ranks #79 among its holdings. This is a return to the name: Port Capital previously reported a position in PFE as recently as Q3 2025.
Port Capital first reported a position in PFE in Q3 2018 and has held it in 30 quarters since. The position peaked at $681K in Q3 2018. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Port Capital held 8,859 shares of Pfizer worth $249K as of Q1 2026.
- Pfizer was a new Port Capital position in Q1 2026.
- Pfizer made up 0.01% of Port Capital's portfolio in Q1 2026, its #79 holding.
- Port Capital first reported a position in Pfizer in Q3 2018 and has held it in 30 quarters since.
- Port Capital's Pfizer position peaked at $681K in Q3 2018.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Port Capital's 13F filing for Q1 2026, filed 15 May 2026.